Solid-State Chemistry Services CRO, Onyx Scientific Reports Increased Demand for Polymorph Screening, Salt Selection and Crystallization Studies
Expert in the provision of solid-state chemistry services for the pharmaceutical and biotech industries, leading global contract research organisation, Onyx Scientific, is delighted to report increased demand in taking candidate compounds from concept through to process development and scale-up of APIs for Phase I and Phase II clinical studies.
"Handling difficult-to-crystallize materials is an art form as well as a science," explains Tony Flinn, CEO, Onyx Scientific. "Inherently complicated, the implications of a well-designed crystallization process are considerable ...







